We are live on ! Find out more
CICI

Capital Investment Counsel Inc Portfolio holdings

AUM $929M
1-Year Est. Return 53.07%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+53.07%
3 Year Est. Return
+153.11%
5 Year Est. Return
+212.22%
10 Year Est. Return
+860.95%
AUM
$279M
AUM Growth
+$6.34M
Cap. Flow
-$2.2M
Cap. Flow %
-0.79%
Top 10 Hldgs %
44.72%
Holding
180
New
5
Increased
36
Reduced
74
Closed
16

Top Buys

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.96M
2
INTC icon
Intel
INTC
+$1.22M
3
FDX icon
FedEx
FDX
+$1.08M
4
WBA
Walgreens Boots Alliance
WBA
+$907K
5
STT icon
State Street
STT
+$647K

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.61M
2
IBM icon
IBM
IBM
+$1.11M
3
KMB icon
Kimberly-Clark
KMB
+$952K
4
RHT
Red Hat Inc
RHT
+$609K
5
PG icon
Procter & Gamble
PG
+$600K

Sector Composition

Rank Sector Weight
1 Technology 37.08%
2 Consumer Staples 17.66%
3 Industrials 8.7%
4 Consumer Discretionary 7.7%
5 Energy 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
101
Bristol-Myers Squibb
BMY
$130B
$422K 0.15%
9,306
+3,150
+51% +$147K
FFIV icon
102
F5
FFIV
$24B
$422K 0.15%
2,900
SNPS icon
103
Synopsys
SNPS
$79B
$420K 0.15%
3,260
-125
-4% -$15K
MRK icon
104
Merck
MRK
$328B
$401K 0.14%
5,010
ISRG icon
105
Intuitive Surgical
ISRG
$142B
$399K 0.14%
2,280
OIH icon
106
VanEck Oil Services ETF
OIH
$1.96B
$390K 0.14%
1,317
-170
-11% -$53K
IT icon
107
Gartner
IT
$11.3B
$385K 0.14%
2,390
XBI icon
108
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$369K 0.13%
4,211
+150
+4% +$12.8K
NUE icon
109
Nucor
NUE
$61.9B
$363K 0.13%
6,580
-200
-3% -$11K
MMM icon
110
3M
MMM
$94.8B
$355K 0.13%
2,448
+33
+1% +$5.08K
SO icon
111
Southern Company
SO
$106B
$349K 0.13%
6,313
-45
-0.7% -$2.41K
DELL icon
112
Dell
DELL
$313B
$345K 0.12%
13,393
+160
+1% +$4.99K
CSX icon
113
CSX Corp
CSX
$92.8B
$337K 0.12%
13,086
NTR icon
114
Nutrien
NTR
$32.1B
$326K 0.12%
6,079
-2,613
-30% -$136K
HII icon
115
Huntington Ingalls Industries
HII
$12.9B
$324K 0.12%
1,441
+1
+0.1% +$214
MO icon
116
Altria Group
MO
$107B
$316K 0.11%
6,664
+1,882
+39% +$98.6K
COLM icon
117
Columbia Sportswear
COLM
$2.88B
$300K 0.11%
3,000
HPE icon
118
Hewlett Packard
HPE
$77.8B
$300K 0.11%
20,091
-523
-3% -$7.93K
ENB icon
119
Enbridge
ENB
$112B
$294K 0.11%
8,151
-64
-0.8% -$2.33K
DAKT icon
120
Daktronics
DAKT
$997M
$286K 0.1%
46,331
-1,150
-2% -$8.01K
EW icon
121
Edwards Lifesciences
EW
$53.6B
$282K 0.1%
4,575
LNC icon
122
Lincoln National
LNC
$8.44B
$281K 0.1%
4,357
+269
+7% +$17.2K
AMD icon
123
Advanced Micro Devices
AMD
$788B
$279K 0.1%
+9,200
New +$262K
AME icon
124
Ametek
AME
$59.3B
$273K 0.1%
3,000
TPR icon
125
Tapestry
TPR
$31.1B
$270K 0.1%
+8,500
New +$265K

Similar funds

Capital Investment Counsel Inc's Q2 2019 Portfolio in Review

As of Q2 2019, Capital Investment Counsel Inc held 180 positions worth $279M, up 2.3% from $272M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Capital Investment Counsel Inc's Q2 2019 filing shows 5 new, 36 increased, 74 reduced and 16 closed positions. Its largest new stake was Walgreens Boots Alliance: 17,070 shares worth $933K. The largest sale was Qualcomm, an estimated $1.61M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Industrials.

  • Capital Investment Counsel Inc's largest Q2 2019 buy was Walgreens Boots Alliance: 17,070 shares worth $933K.
  • Capital Investment Counsel Inc added most to Occidental Petroleum in Q2 2019, an estimated $1.96M increase.
  • Capital Investment Counsel Inc's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $1.61M.
  • Capital Investment Counsel Inc fully exited Vanguard Morningstar Value ETF in Q2 2019, selling an estimated $331K.
  • Capital Investment Counsel Inc's ten largest holdings make up 45% of its $279M portfolio in Q2 2019.
  • Capital Investment Counsel Inc opened 5 new positions and closed 16 in Q2 2019.
  • Capital Investment Counsel Inc's portfolio value rose 2.3% quarter-over-quarter to $279M.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2019, filed 26 Jul 2019.